Seres Therapeutics, Inc. (MCRB)
5.28
-0.28
(-5.04%)
USD |
NASDAQ |
Sep 09, 16:00
5.28
0.00 (0.00%)
After-Hours: 18:12
Seres Therapeutics Price to Book Value : 1.503 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.582 |
| September 04, 2026 | 1.628 |
| September 03, 2026 | 1.605 |
| September 02, 2026 | 1.577 |
| September 01, 2026 | 1.474 |
| August 31, 2026 | 1.397 |
| August 28, 2026 | 1.454 |
| August 27, 2026 | 1.409 |
| August 26, 2026 | 1.355 |
| August 25, 2026 | 1.423 |
| August 24, 2026 | 1.326 |
| August 21, 2026 | 1.298 |
| August 20, 2026 | 1.300 |
| August 19, 2026 | 1.332 |
| August 18, 2026 | 1.235 |
| August 17, 2026 | 1.283 |
| August 14, 2026 | 1.292 |
| August 13, 2026 | 1.275 |
| August 12, 2026 | 1.343 |
| August 11, 2026 | 1.320 |
| August 10, 2026 | 1.423 |
| August 07, 2026 | 1.386 |
| August 06, 2026 | 1.372 |
| August 05, 2026 | 1.424 |
| August 04, 2026 | 1.494 |
| Date | Value |
|---|---|
| August 03, 2026 | 1.431 |
| July 31, 2026 | 1.374 |
| July 30, 2026 | 1.360 |
| July 29, 2026 | 1.323 |
| July 28, 2026 | 1.366 |
| July 27, 2026 | 1.380 |
| July 24, 2026 | 1.413 |
| July 23, 2026 | 1.488 |
| July 22, 2026 | 1.503 |
| July 21, 2026 | 1.494 |
| July 20, 2026 | 1.454 |
| July 17, 2026 | 1.517 |
| July 16, 2026 | 1.474 |
| July 15, 2026 | 1.551 |
| July 14, 2026 | 1.518 |
| July 13, 2026 | 1.599 |
| July 10, 2026 | 1.739 |
| July 09, 2026 | 1.918 |
| July 08, 2026 | 2.032 |
| July 07, 2026 | 2.316 |
| July 06, 2026 | 2.194 |
| July 02, 2026 | 2.203 |
| July 01, 2026 | 2.260 |
| June 30, 2026 | 2.245 |
| June 29, 2026 | 2.820 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 18.09 |
| Anika Therapeutics, Inc. | 2.036 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.693 |
Price to Book Value Related Metrics
| PS Ratio | 26.40 |
| PEG Ratio | -0.0104 |
| Price | 5.28 |
| Earnings Yield | -43.13% |
| Market Cap | 51.89M |
| PEGY Ratio | -0.0104 |